Compared to HFE and TFR2‐HH, JHH carries a greater risk of heart attack, skin change, liver fibrosis, and hypogonadism (Sandhu et al., 2018), allowing easier diagnosis. This evidence concerns the gene TFR2 and hypogonadism.